Fibrosis progression in chronic hepatitis C patients with occult hepatitis B co-infection

Chee-Kin Hui1, Eva Lau, Helen Wu

  • 1Department of Medicine, The University of Hong Kong, Hong Kong SAR, China. ckhui23@gmail.com

Insights

Occult hepatitis B virus (HBV) infection in hepatitis C virus (HCV) patients does not appear to accelerate liver fibrosis progression. Further large-scale studies are needed to confirm this finding regarding HBV/HCV co-infection.

Area of Science:

  • Hepatology
  • Virology
  • Gastroenterology

Background:

  • Occult hepatitis B virus (HBV) infection, defined by detectable HBV DNA without hepatitis B surface antigen (HBsAg), can coexist with hepatitis C virus (HCV) infection.
  • The impact of occult HBV infection on liver fibrosis progression in patients with chronic HCV remains unclear.

Purpose of the Study:

  • To investigate the association between occult HBV infection and the rate of liver fibrosis progression in patients with chronic HCV infection.
  • To compare the incidence of fibrosis progression and development of severe fibrosis (stages 3-4) in HCV patients with and without occult HBV infection.

Main Methods:

  • Retrospective analysis of 74 consecutive anti-HCV positive patients.
  • Diagnosis of occult HBV infection via serum HBV DNA detection using PCR.
  • Assessment of liver fibrosis progression using serial liver biopsies (median 2 per patient) over a median follow-up of 57.7 months.

Main Results:

  • 31 patients (41.9%) were diagnosed with occult HBV infection.
  • Fibrosis progression occurred in 35.5% of patients with occult HBV infection versus 27.9% without (p=0.608).
  • Progression to severe fibrosis (stage 3-4) was observed in 19.4% with occult HBV infection versus 18.6% without (p=0.946).

Conclusions:

  • Occult HBV co-infection in chronic HCV patients does not appear to significantly alter the rate of liver fibrosis progression or the development of severe fibrosis.
  • Larger, prospective studies are warranted to definitively establish the role of occult HBV infection in HCV-related liver disease progression.

Related Concept Videos

Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Chronic Pancreatitis II: Pathophysiology01:21

Chronic Pancreatitis II: Pathophysiology

Chronic pancreatitis is a progressive and irreversible inflammation of the pancreas, most often caused by long-term alcohol abuse, but it can also be related to ductal obstruction, smoking, or genetic factors.Chronic pancreatitis occurs when the pancreas is repeatedly exposed to harmful agents like alcohol, smoking, ductal obstruction, or genetic predisposition. These factors lead to the release of toxic metabolites and inflammatory cytokines, sustaining chronic inflammation in the pancreatic...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...